Privia Health Group, Inc. (NASDAQ: PRVA) had its price target raised by analysts at Robert W. Baird from $24.00 to $26.00. They now have an "outperform" rating on the stock.
Privia Health Group, Inc. (NASDAQ: PRVA) had its price target raised by analysts at Barclays PLC from $21.00 to $23.00. They now have an "equal weight" rating on the stock.
Privia Health Group, Inc. (NASDAQ: PRVA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
1 of Wall Street's Favorite Stock to Research Further and 2 to Steer Clear Of [Yahoo! Finance]
Privia Health Enters Arizona In Partnership with Integrated Medical Services